Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more

Although cancer immunotherapy using immune checkpoint inhibitors (ICIs) has been recognized as one of the major treatment modalities for malignant diseases, the clinical outcome is not uniform in all cancer patients. Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Masahiko, Nanno, Kotaro, Yoshimori, Daigo, Nakajima, Takahiro, Takada, Makoto, Yazawa, Takashi, Mimura, Kousaku, Inoue, Norio, Watanabe, Takafumi, Tachibana, Kazunoshin, Muto, Satoshi, Momma, Tomoyuki, Suzuki, Yoshiyuki, Kono, Koji, Endo, Shungo, Takenoshita, Seiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671473/
https://www.ncbi.nlm.nih.gov/pubmed/36395389
http://dx.doi.org/10.18632/oncotarget.28303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671473/
https://www.ncbi.nlm.nih.gov/pubmed/36395389
http://dx.doi.org/10.18632/oncotarget.28303

Ejemplares similares